Peter Soparkar, See Remarks section at Adverum Biotechnologies, Inc. (ADVM), bought 21,925 shares at $1.14 ($25K) on 2022-04-19, disclosed to the SEC on 2022-04-20.
Open-market purchase of $25k ADVM by See Remarks section. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.14 | 175 | $199 | 0.8% |
| 2 | $1.14 | 21,750 | $25K | 99.2% |
| Total | $1.14 avg | 21,925 | $25K | 100% |
| Filing → |
| ADVM | SELL | 2023-03-17 | $10K | — | Filing → |
| ADVM | SELL | 2022-09-21 | $14K | — | Filing → |
| ADVM | BUY | 2021-12-10 | $48K | — | Filing → |